Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UBIS (Asia) PCLBKK:UBIS-R +68.97%65 3-Year EBITDA Growth Rate is 57.30% as of Jun. 2026, which is 1810% above its 10-year median of 3.00. GuruFocus rates BKK:UBIS-R with a GF Score™ of 65/100 and a GF Value™ of ฿1.58. The stock has 7 warning signs investors should review. Among 1,409 Chemicals companies, UBIS (Asia) PCL ranks better than 95.1% on this metric.
During the past 12 months, UBIS (Asia) PCL's average EBITDA Per Share Growth Rate was 279.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 57.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of UBIS (Asia) PCL was 57.30% per year. The lowest was -56.20% per year. And the median was 3.00% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
UBIS (Asia) PCL 3-Year EBITDA Growth Rate Related Terms
BKK:UBIS-R vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, UBIS (Asia) PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UBIS (Asia) PCL 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, UBIS (Asia) PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where UBIS (Asia) PCL's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 57.30% mean?
UBIS (Asia) PCL (BKK:UBIS-R) has a 3-Year EBITDA Growth Rate of 57.30% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for UBIS (Asia) PCL and its competitors. This is 1810% above median its historical median of 3.00. According to the industry distribution chart, UBIS (Asia) PCL ranks #69 out of 1409 companies in the Chemicals industry, placing it in the top 4.9%.
Is UBIS (Asia) PCL's 3-Year EBITDA Growth Rate too high?
UBIS (Asia) PCL's current 3-Year EBITDA Growth Rate of 57.30% is 1810% above median its 10-year median of 3.00. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.80. UBIS (Asia) PCL's value of 57.30% is 7062.5% above this industry median. Based on the distribution chart, UBIS (Asia) PCL ranks #69 out of 1409 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, UBIS (Asia) PCL has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does UBIS (Asia) PCL's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, UBIS (Asia) PCL ranks #69 out of 1409 companies for 3-Year EBITDA Growth Rate. This places UBIS (Asia) PCL in the top 5% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.80. UBIS (Asia) PCL's value of 57.30% is 7062.5% above this benchmark. While the company's 10-year median is 3.00 vs. the industry median of 0.80, UBIS (Asia) PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UBIS (Asia) PCL's current 3-Year EBITDA Growth Rate of 57.30% is 7062.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for UBIS (Asia) PCL and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UBIS (Asia) PCL's current 3-Year EBITDA Growth Rate is 57.30%, which is 1810% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UBIS (Asia) PCL stock overvalued right now?
UBIS (Asia) PCL (BKK:UBIS-R) has a current 3-Year EBITDA Growth Rate of 57.30%. The stock's GF Value™ is ฿1.58, compared to a current price of ฿1.69 — trading 6.9% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 57.30%, which is 1810% above median its 10-year median of 3.00 and 7062.5% above the Chemicals industry median of 0.80. UBIS (Asia) PCL's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For UBIS (Asia) PCL (BKK:UBIS-R), the current 3-Year EBITDA Growth Rate is 57.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UBIS (Asia) PCL (BKK:UBIS-R) Overvalued in 2026?
Based on GuruFocus' analysis, UBIS (Asia) PCL stock appears to be overvalued.
The current stock price of ฿1.69 is trading 6.9% above its estimated GF Value™ of ฿1.58.
Key valuation signals for BKK:UBIS-R:
3-Year EBITDA Growth Rate: 57.30% (1810% above median its 10-year median of 3.00)
GF Value™: ฿1.58 vs. price of ฿1.69 (6.9% above fair value)
Industry Position: 7062.5% above the Chemicals median (#69 of 1409)
No single metric tells the full story. See the BKK:UBIS-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UBIS (Asia) PCL is engaged in the business of manufacturing and distributing of sealing compounds, lacquers, and coatings used in can production and bottle closure for the food, beverage, and general industries. It operates in two business segments, each offering different products and services: Manufacturer and distributor of sealing compounds, lacquers and coatings and Other business The majority of the revenue is generated from the Manufacturer of sealing compounds, lacquers and coatings segment. Company operates in Thailand, China, and Others, with the majority of revenue from Other segment.
65GF Score
Get the complete analysis for BKK:UBIS-R
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:UBIS-R has been successfully added to your 
